Anti-VEGF monotherapy treatment strategies for neovascular AMD

Jaclyn L. Kovach, Stephen G. Schwartz, Harry W. Flynn, Ingrid U. Scott

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This chapter provides a review of the discovery of anti-vascular endothelial growth factor (VEGF) agents, the evolution of drug development, and the refinement of evidence-based treatment strategies for neovascular AMD.

Original languageEnglish (US)
Title of host publicationStudies on Retinal and Choroidal Disorders
PublisherHumana Press Inc.
Pages479-499
Number of pages21
ISBN (Electronic)9781617796067
ISBN (Print)9781617796050
DOIs
StatePublished - Jan 1 2012

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Anti-VEGF monotherapy treatment strategies for neovascular AMD'. Together they form a unique fingerprint.

Cite this